RxDoctor Payments Data

Jacob Bollinger

Physician Assistant · Salisbury, MDNPI 1952944316

Payments from drug & device makers

$1,814in general payments, 2019–2025

Across 94 payments — averaging $19.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$404
  • Amgen$298
  • Novo Nordisk$228
  • Pfizer$162
  • Takeda Pharmaceuticals U.S.A., Inc.$116
  • AstraZeneca$91
  • plus $515 from 12 others

What the payments were for

  • Food & beverage$1,72495%
  • Education$905%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,814 in reported general payments places this provider in the 85th percentile of 2,567 physician assistant providers in Maryland.

See all physician assistant providers in Maryland

Medicare billing

Part B allowed, 2024
$144,585
Medicare patients
660
Services billed
1,946

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$46,491
MounjaroTirzepatide32$45,984
EliquisApixaban40$42,815
Trelegy ElliptaFluticasone/Umeclidin/Vilanter61$42,452
JardianceEmpagliflozin40$41,523
TrulicityDulaglutide14$30,589
GemtesaVibegron15$12,204
BelsomraSuvorexant18$11,852
Rosuvastatin Calcium166$3,951
Gabapentin157$3,270
Albuterol Sulfate HfaAlbuterol Sulfate84$2,622
Atorvastatin Calcium166$2,359
SynthroidLevothyroxine Sodium28$2,069
Celecoxib37$1,765
Potassium Chloride74$1,540

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$404$76,57246 claims
Novo NordiskOzempic$228$46,49139 claims
PfizerEliquis$162$42,81540 claims
GSKTrelegy Ellipta$17$42,45261 claims
Boehringer IngelheimJardiance$38$41,52340 claims
Sumitomo Pharma America, Inc.Gemtesa$85$12,20415 claims
MerckBelsomra$47$11,85218 claims
AbbVieSynthroid$29$2,06928 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,567 physician assistant providers in Maryland.

Other physician assistant in Salisbury

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →